Avenue Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 11 Dec 23 | SellUS$86,560 | Robert Davidow | Individual | 8,226.65 | US$11.25 | |
| 08 Sep 23 | BuyUS$301,255 | Fortress Biotech, Inc. | Company | 5,578.79 | US$54.00 | |
| 08 Sep 23 | BuyUS$251,046 | Lindsay Rosenwald | Individual | 4,648.99 | US$54.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 90 | 0.0153% |
| Institutions | 16,394 | 2.78% |
| Individual Insiders | 22,417 | 3.8% |
| Public Companies | 47,298 | 8.01% |
| General Public | 503,941 | 85.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 458.8%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 47,298 | US$237.0k | 244% | no data | |||
| 17,464 | US$87.5k | 0% | no data | |||
| 8,814 | US$44.2k | 0% | 0.32% | |||
| 4,671 | US$23.4k | -1.12% | no data | |||
| 3,347 | US$16.8k | 0% | 0.01% | |||
| 1,181 | US$5.9k | 0% | no data | |||
| 695 | US$3.5k | -0.71% | no data | |||
| 617 | US$3.1k | 0% | no data | |||
| 407 | US$2.0k | 0% | no data | |||
| 381 | US$1.9k | 0% | no data | |||
| 366 | US$1.8k | 90.6% | no data | |||
| 337 | US$1.7k | 0% | no data | |||
| 145 | US$726.4 | 0% | no data | |||
| 119 | US$596.1 | 58.7% | no data | |||
| 119 | US$596.1 | 58.7% | no data | |||
| 90 | US$450.9 | -1.1% | no data | |||
| 60 | US$300.7 | 0% | no data | |||
| 44 | US$220.6 | 0% | no data | |||
| 16 | US$80.1 | -33.3% | no data | |||
| 14 | US$70.1 | 0% | no data | |||
| 7 | US$35.2 | 0% | no data | |||
| 6 | US$30.2 | 500% | no data | |||
| 1 | US$5.0 | 0% | no data |